A Randomized, Double Blind, Placebo Controlled, Multicenter, Multiple Ascending Dose Study to Evaluate the Safety and Tolerability of HTD1801 in Adults With Hypercholesterolemia
Phase of Trial: Phase I/II
Latest Information Update: 17 Jan 2019
At a glance
- Drugs HTD 1801 (Primary)
- Indications Hypercholesterolaemia
- Focus Adverse reactions
- Sponsors HighTide Biopharma
- 09 Jan 2019 Status changed from recruiting to completed.
- 22 Feb 2018 Status changed from not yet recruiting to recruiting.
- 02 Jan 2018 New trial record